Discover the full directors' dealings record of TRANSCAT INC, a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Industry sector, TRANSCAT INC has logged 18 public disclosures. Market capitalisation: €701.5m. The latest transaction was reported on 12 November 2021 — Cession. Among the most active insiders: HARRISON RICHARD J. Every trade is accessible without an account.
18 of 18 declarations
Transcat Inc. is a U.S.-based industrial services and test-and-measurement company listed on the Nasdaq Global Market under ticker TRNS, with headquarters in Rochester, New York, United States. Founded in 1964 in Ohio, the company evolved from an industrial-grade calibration tools manufacturer into a specialized provider of technical services and value-added measurement equipment. For French-speaking investors, Transcat fits a niche industrial profile at the intersection of calibration, compliance, and mission-critical equipment support. The business is organized into two highly complementary operating segments: Service and Distribution. The Service segment is the strategic core of the model. It includes accredited calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, validation, Computerized Maintenance Management System (CMMS) solutions, and pipette services. Transcat primarily serves highly regulated end markets, especially life sciences, including pharmaceuticals, biotechnology, medical devices, and other FDA-regulated businesses. It also serves industrial manufacturing, energy and utilities, oil and gas, chemical manufacturing, and FAA-regulated customers such as aerospace and defense. The Distribution segment extends the offering through the sale and rental of professional-grade handheld test, measurement, and control instrumentation from approximately 400 brands. The company markets more than 75,000 instruments and adds value by calibrating products before shipment, which allows customers to put equipment into service immediately upon receipt. Additional offerings include equipment kitting, rentals, and used-equipment sales. This integration between distribution and calibration services creates a differentiated proposition and helps raise competitive barriers versus more narrowly focused peers. Geographically, Transcat remains predominantly U.S.-anchored but has a broader North American and European footprint. Its service centers, client-based labs, mobile calibration units, and distribution locations span the United States, Puerto Rico, Canada, and Ireland. That network supports a recurring, proximity-based service model and deepens customer relationships in regulated industries. Recent corporate developments reinforce the company’s acquisition-led growth strategy. In fiscal 2025 and into 2026, Transcat expanded through acquisitions including Martin Calibration and Becnel Rental Tools, followed by Essco Calibration Laboratory and SCM Metrology and Laboratories. The company also rebranded NEXA as Transcat Solutions, broadening its asset management and compliance-related capabilities for biopharmaceutical customers. Overall, Transcat’s profile is that of a disciplined industrial compounder with recurring service revenue, technical expertise, and a consolidation strategy in fragmented, compliance-intensive markets.